Treatment of Long-haul Disease (COVID-19) Autoimmune Encephalitis With Plasmapheresis

Tony Kamel • William Toppen • Yasaman Salahmand, DOI: 10.7759/cureus.85150  Abstract In December 2021, a 58-year-old unvaccinated woman with a past medical history of obesity presented to an outside hospital with severe coronavirus disease 2019…[...]

Read More

🧠 COVID-19 and Neurological Injury: Mechanisms, Irreversibility, and Therapeutic Approaches

The SARS-CoV-2 was developed as a neurological bioweapon, extensive research has documented its neuroinvasive potential, neuropathological effects, and long-term neurological consequences. This article synthesizes findings from 2024–2025 peer-reviewed studies to…[...]

Read More

🫁 Long COVID and Shortness of Breath: Causes, Vaccine-Linked Harms, and Emerging Treatments (2025 Overview)

Five years into the pandemic, shortness of breath remains one of the most persistent and debilitating symptoms of Long COVID, affecting millions globally. This article synthesizes findings from 2025 peer-reviewed…[...]

Read More

Increased frequency and mortality in persons with neurological disorders during COVID-19 

Candace M Marsters, Jeffrey A Bakal, Grace Y Lam, Finlay A McAlister, Christopher Power, Brain, awae117, https://doi.org/10.1093/brain/awae117, 20 April 2024 Abstract Determining the frequency and outcomes of neurological disorders associated with coronavirus disease 2019 (COVID-19)…[...]

Read More

Pathophysiology, diagnosis, and management of neuroinflammation in covid-19

BMJ 2023; 382 doi: https://doi.org/10.1136/bmj-2022-073923 (Published 18 August 2023)Cite this as: BMJ 2023;382:e073923, Rachel L Brown123,  Laura Benjamin24,  Michael P Lunn12,  Tehmina Bharucha25,  Michael S Zandi12,  Chandrashekar Hoskote6,  Patricia McNamara2,  Hadi Manji1 Abstract Although neurological complications of…[...]

Read More